Maarten Sijm
Amsterdam, NH 1081HZ, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
To Target or Not to Target Schistosoma mansoni Cyclic Nucleotide Phosphodiesterase 4A?
Journal: International journal of molecular sciences
Published: February 07, 2023
Structure Activity Relationship of N-Substituted Phenyldihydropyrazolones Against Trypanosoma cruzi Amastigotes.
Journal: Frontiers in chemistry
Published: September 20, 2020
Efficacy of Novel Pyrazolone Phosphodiesterase Inhibitors in Experimental Mouse Models of Trypanosoma cruzi.
Journal: Antimicrobial agents and chemotherapy
Published: March 05, 2020
Structure-Activity Relationship of Phenylpyrazolones against Trypanosoma cruzi.
Journal: ChemMedChem
Published: March 03, 2020
Identification of Phenylphthalazinones as a New Class of Leishmania infantum Inhibitors.
Journal: ChemMedChem
Published: September 20, 2019
Identification of Phenylpyrazolone Dimers as a New Class of Anti-Trypanosoma cruzi Agents.
Journal: ChemMedChem
Published: June 19, 2019
Screening of a PDE-focused library identifies imidazoles with in vitro and in vivo antischistosomal activity.
Journal: International journal for parasitology. Drugs and drug resistance
Published: November 15, 2018
Targeting a Subpocket in Trypanosoma brucei Phosphodiesterase B1 (TbrPDEB1) Enables the Structure-Based Discovery of Selective Inhibitors with Trypanocidal Activity.
Journal: Journal of medicinal chemistry
Published: April 20, 2018
A novel series of histamine H4 receptor antagonists based on the pyrido[3,2-d]pyrimidine scaffold: comparison of hERG binding and target residence time with PF-3893787.
Journal: Bioorganic & medicinal chemistry letters
Published: January 05, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026